Goldman Sachs
TNYA icon

Goldman Sachs’s Tenaya Therapeutics TNYA Stock Holding History

Goldman Sachs’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Buy
294,739
+139,938
+90% +$106K ﹤0.01% 6162
2026
Q1 		$107K Buy
154,801
+86,824
+128% +$64.1K ﹤0.01% 6199
2025
Q4 		$48.4K Sell
67,977
-159,520
-70% -$217K ﹤0.01% 6291
2025
Q3 		$369K Sell
227,497
-52,726
-19% -$53.1K ﹤0.01% 5662
2025
Q2 		$171K Buy
280,223
+69,052
+33% +$35.1K ﹤0.01% 5702
2025
Q1 		$120K Sell
211,171
-94,837
-31% -$93.6K ﹤0.01% 5749
2024
Q4 		$438K Sell
306,008
-9,794
-3% -$22K ﹤0.01% 5324
2024
Q3 		$609K Buy
315,802
+95,819
+44% +$271K ﹤0.01% 4942
2024
Q2 		$682K Buy
219,983
+137,871
+168% +$569K ﹤0.01% 4657
2024
Q1 		$429K Buy
82,112
+7,627
+10% +$36.5K ﹤0.01% 4816
2023
Q4 		$241K Sell
74,485
-44,303
-37% -$95.6K ﹤0.01% 5083
2023
Q3 		$303K Buy
118,788
+43,517
+58% +$182K ﹤0.01% 4892
2023
Q2 		$442K Buy
75,271
+52,974
+238% +$308K ﹤0.01% 4808
2023
Q1 		$63.5K Sell
22,297
-18,649
-46% -$52.4K ﹤0.01% 5518
2022
Q4 		$82.3K Buy
40,946
+1,423
+4% +$3.47K ﹤0.01% 5519
2022
Q3 		$115K Buy
39,523
+20,275
+105% +$94.6K ﹤0.01% 5654
2022
Q2 		$108K Sell
19,248
-7,923
-29% -$64.1K ﹤0.01% 5837
2022
Q1 		$320K Buy
27,171
+12,870
+90% +$156K ﹤0.01% 5624
2021
Q4 		$271K Buy
+14,301
New +$312K ﹤0.01% 5723

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs's TNYA Position: Q2 2026 in Review

Goldman Sachs increased its Tenaya Therapeutics (TNYA) stake by 90% in Q2 2026, buying an estimated $106K and bringing the position to 294,739 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #6162.

Goldman Sachs first reported a position in TNYA in Q4 2021 and has held it in 19 quarters since. The position peaked at $682K in Q2 2024. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Goldman Sachs held 294,739 shares of Tenaya Therapeutics worth $218K as of Q2 2026.
  • Goldman Sachs bought 139,938 Tenaya Therapeutics shares in Q2 2026, an estimated $106K.
  • Tenaya Therapeutics made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #6162 holding.
  • Goldman Sachs first reported a position in Tenaya Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • Goldman Sachs's Tenaya Therapeutics position peaked at $682K in Q2 2024.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.